JMKX000189 / Shanghai Jeyou Pharmaceutical - LARVOL DELTA

Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: Shanghai Jeyou Pharmaceutical Co., Ltd.

New P1 trial • Pain

A multicenter, randomized, double-blind, placebo-controlled phase II/III clinical study to evaluate the efficacy and safety of JMKX000189 tablets in inducing and maintaining treatment of moderate to severe active ulcerative colitis (ChiCTR) - P2/3 | N=677 | Recruiting | Sponsor: The First Affiliated Hospital of Sun Yat sen University; Shanghai Jiyu Pharmaceutical Co., LTD

New P2/3 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis • CRP

JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus (clinicaltrials.gov) - P2a | N=48 | Recruiting | Sponsor: Jemincare

New P2a trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus